Spineguard Valuation
| ALSGD Stock | EUR 0.08 0 3.70% |
Spineguard seems to be fairly valued based on Macroaxis valuation methodology. Our model measures the value of Spineguard from inspecting the company fundamentals such as Shares Outstanding of 31.71 M, return on equity of -0.43, and Operating Margin of (0.33) % as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Spineguard's price fluctuation is out of control at this time. Calculation of the real value of Spineguard is based on 3 months time horizon. Increasing Spineguard's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Spineguard's intrinsic value may or may not be the same as its current market price of 0.08, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.084 | Real 0.0806 | Hype 0.08 | Naive 0.0827 |
The intrinsic value of Spineguard's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Spineguard's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Spineguard helps investors to forecast how Spineguard stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Spineguard more accurately as focusing exclusively on Spineguard's fundamentals will not take into account other important factors: Spineguard Total Value Analysis
Spineguard is presently projected to have takeover price of 18.77 M with market capitalization of 33.05 M, debt of 3.61 M, and cash on hands of 1.06 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Spineguard fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
18.77 M | 33.05 M | 3.61 M | 1.06 M |
Spineguard Investor Information
The book value of the company was presently reported as 0.16. The company recorded a loss per share of 0.08. Spineguard had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Spineguard's historical financial statements, Spineguard is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.Spineguard Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Spineguard has an asset utilization ratio of 37.02 percent. This connotes that the Company is making €0.37 for each dollar of assets. An increasing asset utilization means that Spineguard is more efficient with each dollar of assets it utilizes for everyday operations.Spineguard Ownership Allocation
Spineguard shows a total of 31.71 Million outstanding shares. About 98.73 % of Spineguard outstanding shares are held by general public with 1.27 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Spineguard Profitability Analysis
The company reported the revenue of 4.41 M. Net Loss for the year was (1.72 M) with profit before overhead, payroll, taxes, and interest of 3.61 M.About Spineguard Valuation
The stock valuation mechanism determines Spineguard's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Spineguard based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Spineguard. We calculate exposure to Spineguard's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Spineguard's related companies.The companys PediGuard products are handheld devices that detect possible vertebral cortex perforation during pedicle preparation for screw placement, and alerts surgeons prior to a breach by analyzing the electrical conductivity of the surrounding tissues in real time. SpineGuard SA was founded in 2009 and is headquartered in Vincennes, France. SPINEGUARD operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 19 people.
8 Steps to conduct Spineguard's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Spineguard's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Spineguard's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Spineguard's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Spineguard's revenue streams: Identify Spineguard's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Spineguard's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Spineguard's growth potential: Evaluate Spineguard's management, business model, and growth potential.
- Determine Spineguard's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Spineguard's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Spineguard Stock Analysis
When running Spineguard's price analysis, check to measure Spineguard's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineguard is operating at the current time. Most of Spineguard's value examination focuses on studying past and present price action to predict the probability of Spineguard's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineguard's price. Additionally, you may evaluate how the addition of Spineguard to your portfolios can decrease your overall portfolio volatility.